Package 63739-008-33

{"route": ["ORAL"], "spl_id": "2b9c5378-33d7-6d41-e063-6294a90a6f54", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["349434"], "spl_set_id": ["aa18d6fa-8a5c-4c69-b4db-6ae578165d7d"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Mckesson Corporation DBA SKY Packaginng"]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-008-33)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "63739-008-33", "marketing_end_date": "20260228", "marketing_start_date": "20160531"}], "brand_name": "Voriconazole", "product_id": "63739-008_2b9c5378-33d7-6d41-e063-6294a90a6f54", "dosage_form": "TABLET", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "63739-008", "generic_name": "Voriconazole", "labeler_name": "Mckesson Corporation DBA SKY Packaginng", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "200 mg/1"}], "application_number": "ANDA206181", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20160531"}